CD8A and B-cell chronic lymphocytic leukemia: In chronic lymphocytic leukemia (CLL) patients treated with BBz CAR-T cell therapy, responders presented increased frequencies of early memory CD8+ T cells in their apheresis products, and these patients demonstrated significantly increased CAR-T cell expansion postinfusion (37).